Kintara Therapeutics Inc

+0.01 (+5.40%)
Earnings Announcements

Kintara Therapeutics Posts Qtrly Net Loss Per Share $0.11

Published: 05/13/2022 12:23 GMT
Kintara Therapeutics Inc (KTRA) - Kintara Therapeutics Announces Fiscal 2022 Third Quarter Financial Results and Provides Corporate Update.
Kintara Therapeutics Inc - at March 31, 2022, Kintara Had Cash and Cash Equivalents of Approximately $8.8 Million.
Kintara Therapeutics Inc - for Three Months Ended March 31, 2022, Kintara Reported a Net Loss of Approximately $5.4 Million, Or $0.11 per Share.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.02

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.